Swinging Opportunities In Exchange Stocks
Heightened volatility across most asset classes over the last two months has led to a surge in trading volumes – and to exchange stocks (the…
On the Radar Reports
Upside Potential In The Pipelines: 3 “Strong Buy” Biotech Stocks To Consider
Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those…
Biotech’s Historic Month (And Whether It Can Last)
After three straight months of losses, April brought the S&P 500 health care sector its best one-month gain in twenty years, and today’s article notes…
More Evidence That Biotech Is The “Next Gold Mine”
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…
Are These Biotech And Energy Stocks The Best Penny Stock Picks Right Now?
In the world of penny stocks, biotech penny stocks and energy penny stocks have been among the big movers recently – and the author of…
3 “Compelling” Biotech Stocks With Small Price Tags And Big Upside Potential
In assessing the current market environment, the author of today’s article notes that “it becomes apparent that there’s an opportunity for those able to take…
What Are Insiders Seeing In This Clinical-Stage Biotech?
The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…
3 Penny Stocks With High Profit Potential
Considering the state of affairs right now, investors may be reluctant to buy expensive stocks. Thankfully, there’s penny stocks. As the author of today’s article…
“Imminent Danger”: These 4 Energy Stocks Could Be Kicked Out Of The S&P 500
Thanks to it ensuring a ready supply of buyers, buying stocks that are about to be included in the S&P 500 has proven to be…
Don’t Overlook This Cancer Biotech In The Age Of Coronavirus
This clinical-stage biopharmaceutical company focused on developing treatments for different kinds of cancers just recently launched an IPO, making it just the second IPO to…